SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob L who wrote (51)6/28/2000 11:47:00 AM
From: scaram(o)uche  Read Replies (1) of 724
 
Want to make one other thing clear -- my valuation of DGI is based on the issued patent and the expansion of the Novo deal. If they can do and have done what they describe here.......

dgibt.com

and if the quality of their work resembles that of the SAB, then I would place a higher value on DGI.

This is my concept (please, everyone get their own!) of how to invest in biotech...... find leveraged (and, if possible, also under-valued) opportunities, and invest early. Work hard to find out that the company stinks before the next guy can do such, and, if it doesn't stink, stick.

It works. Other schemes also work well (see V1/Suzman/Silverman in 1998, for example). But this mechanism has worked, exceptionally, for over five years. It's largely documented here at SI. That's why I barf whenever I see one of these "how to invest in biotech" gurus, with "only buy companies with profits and late-stage projects" in their list of criteria.

Ick. I feel tainted, just from typing it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News